The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Vion Pharmaceuticals, Inc.

Vion Pharmaceuticals, Inc.
Nasdaq: VION
Change
symbol:
     
 PROFILE
Vion Pharmaceuticals wants to bring forth the scion of cancer treatment. The development-stage firm, however, has suffered a setback. Its lead anti-cancer product, Promycin, which targets radiation-resistant oxygen-depleted tumor cells, failed to meet expectations in trials for head and neck cancer, so partner Boehringer Ingelheim has curtailed development. Vion focuses now on TAPET (tumor amplified protein expression therapy), drug delivery technology that uses genetically altered Salmonella strains to deliver anticancer drugs. TAPET itself may fight melanoma and breast, colon, and lung cancer with minimized side effects. Other drug candidates include Triapine, designed to prevent tumor cells from replicating.

 COMPETITION
Cell Therapeutics, Inc. (CTIC)
GenStar Therapeutics Corporation (GNT)
Genzyme Molecular Oncology (GZMO)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.90
1-Yr. Sales Growth: (71.9)%
Employees: 54
Revenue per employee: $16,666.67

 KEY PEOPLE
• Alan Kessman
    CEO
• Steven H. Koehler
    CFO

 CONTACT INFO
4 Science Park
New Haven, CT 06511
US
Phone: 203-498-4210
Fax: 203-498-4211
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001